Yonghua Wang
7PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 03, 2026
Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancer.Chengquan Shen, Changxue Liu, Ding Hu
|Jul 15, 2025
Tumor-intrinsic ENO1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD-L1 immunotherapy in bladder cancer.Chengquan Shen, Jing Liu, Ding Hu
|Feb 07, 2022
Bioinformatics Analysis of Prognostic Value of SPC24 in ccRCC and Pan-Cancer.Jipeng Zhang, Xinlei Chen, Jirong Wang
|May 25, 2021
TEAD4 is an Immune Regulating-Related Prognostic Biomarker for Bladder Cancer and Possesses Generalization Value in Pan-Cancer.Jirong Wang, Chengquan Shen, Jipeng Zhang
|Jan 18, 2021
Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer.Chengquan Shen, Ting Xu, Yefeng Sun
|Dec 09, 2020
Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer.Chengquan Shen, Jing Liu, Liping Wang
Pageof 2
